Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis.
Neuromyelitis optica spectrum disorder: 2-deoxy-2-[(18)f]fluoro-d-glucose positron emission tomography findings.
Patients with migraine do not have MRI-visible cortical lesions.
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis.
Editorial for JNV issue on PML.
[The influence of locomotor treatment using robotic body-weight-supported treadmill training on rehabilitation outcome of patients suffering from neurological disorders].
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells.
A genome screen for multiple sclerosis in Italian families.
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients.
Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials.
Suppression of Murine Experimental Autoimmune Optic Neuritis by Mature Dendritic Cells Transfected with Calcitonin Gene-Related Peptide Gene.
Development of the Brief Inventory of Perceived Stress.
Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Compared to Daily COPAXONE® 20 mg
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.
A comparative study of experimental mouse models of central nervous system demyelination.
Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.

Pages